Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 5, 2009, Pages 2153-2155

  Rodríguez, M Mar ^a   Calvo, Enrique ^a   Serena, Carolina ^a   Mariné, Marçal ^a   Pastor, F Javier ^a   Guarro, Josep ^a,b  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; MICAFUNGIN; VORICONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; FUNGUS ISOLATION; MALE; MONOTHERAPY; MOUSE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS; SURVIVAL; TREATMENT RESPONSE;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; BRAIN; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, FUNGAL; DRUG THERAPY, COMBINATION; ECHINOCANDINS; HUMANS; KIDNEY; LIPOPEPTIDES; MALE; MICE; MICROBIAL SENSITIVITY TESTS; MYCETOMA; PYRIMIDINES; SCEDOSPORIUM; TREATMENT OUTCOME; TRIAZOLES;

EID: 66149108335     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01477-08     Document Type: Article

References (23)

1. Bocanegra, R., L. K. Najvar, S. Hernandez, D. I. McCarthy, and J. R. Graybill. 2005. Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis. Antimicrob. Agents Chemother. 49:5139-5141. (Pubitemid 41778935)
2. Capilla, J., C. Yustes, E. Mayayo, B. Fernández, M. Ortoneda, F. J. Pastor, and J. Guarro. 2003. Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits. Antimicrob. Agents Chemother. 47:1948-1951.
3. Cortez, K. J., E. Roilides, F. Quiroz-Telles, J. Meletiadis, C. Antachopoulos, T. Knudsen, W. Buchanan, J. Milanovich, D. A. Sutton, A. Fothergill, M. G. Rinaldi, Y. R. Shea, T. Zaoutis, S. Kottilil, and T. J. Walsh. 2008. Infections caused by Scedosporium spp. Clin. Microbiol. Rev. 21:157-197.
4. Cuenca-Estrella, M., A. Alastruey-Izquierdo, L. Alcazar-Fuoli, L. Bernal- Martinez, A. Gomez-Lopez, M. J. Buitrago, E. Mellado, and J. L. Rodriguez- Tudela. 2008. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrob. Agents Chemother. 52:1136-1139.
5. Dannaoui, E., O. Lortholary, and F. Dromer. 2004. In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob. Agents Chemother. 48:970-978. (Pubitemid 38280351)
6. Eliopoulos, G. M., and R. C. Moellering. 1991. Antimicrobial combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams & Wilkins Co., Baltimore, MD.
7. Guarro, J., A. S. Kantarcioglu, R. Horré, J. L. Rodríguez-Tudela, M. Cuenca-Estrella, J. Berenguer, and G. S. De Hoog. 2006. Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med. Mycol. 44:295-327.
8. Husain, S., P. Muñoz, G. Forrest, B. D. Alexander, J. Somani, K. Brennan, M. M. Wagener, and N. Singh. 2005. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin. Infect. Dis. 40:89-99.
9. Idigoras, P., E. Perez-Trallero, L. Pineiro, J. Larruskain, M. C. Lopez- Lopategui, N. Rodriguez, and J. M. Gonzalez. 2001. Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999. Clin. Infect. Dis. 32:158-165.
10. Johnson, M. D., C. MacDougall, L. Ostrosky-Zeichner, J. R. Perfect, and J. H. Rex. 2004. Combination antifungal therapy. Antimicrob. Agents Chemother. 48:693-715. (Pubitemid 38280314)
11. Lewis, R. E., N. D. Albert, and D. P. Kontonyiannis. 2008. Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis. J. Antimicrob. Chemother. 61:1140-1144.
12. Maertens, J., K. Lagrou, H. Deweerdt, I. Surmont, G. E. Verhoef, J. Verhaegen, and M. A. Boogaerts. 2000. Disseminated infection by Scedosporium prolificans: an emerging fatality among hematology patients. Case report and review. Ann. Hematol. 79:340-344.
13. Majithiya, J., A. Sharp, A. Parmar, D. W. Denning, and P. A. Warn. 2009. Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei. J. Antimicrob. Chemother. 63:161-166.
14. Meletiadis, J., J. F. G. M. Meis, J. W. Mouton, J. L. Rodriguez-Tudela, J. P. Donnelly, P. E. Verweij, and the EUROFUNG Network. 2002. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob. Agents Chemother. 46:62-68.
15. NCCLS/CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard, 2nd ed. Document M38-A2. NCCLS/CLSI, Wayne, PA.
16. Ortoneda, M., J. Capilla, F. J. Pastor, C. Serena, and J. Guarro. 2004. Interaction of granulocyte colony-stimulating factor and high doses of liposomal amphotericin B in the treatment of systemic murine scedosporiosis. Diagn. Microbiol. Infect. Dis. 50:247-251. (Pubitemid 39593147)
17. Ortoneda, M., J. Capilla, I. Pujol, F. J. Pastor, E. Mayayo, J. Fernández- Ballart, and J. Guarro. 2002. Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans. J. Antimicrob. Chemother. 49:525-529. (Pubitemid 34223674)
18. Rodriguez-Tudela, J. L., J. Berenguer, J. Guarro, A. S. Kantarcioglu, R. Horre, G. S. De Hoog, and M. Cuenca-Estrella. 2008. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med. Mycol. 1:1-12.
19. Serena, C., F. J. Pastor, M. Mariné, M. M. Rodríguez, and J. Guarro. 2008. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection. J. Antimicrob. Chemother. 61:877-879.
20. Sugar, A. M., and X. Liu. 2001. Efficacy of voriconazole in treatment of murine pulmonary blastomycosis. Antimicrob. Agents Chemother. 45:601-604. (Pubitemid 32105301)
21. Troke, P., K. Aguirrebengoa, C. Arteaga, D. Ellis, C. H. Heath, I. Lutsar, M. Rovira, Q. Nguyen, M. Slavin, and S. C. A. Chen. 2008. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob. Agents Chemother. 52:1743-1750.
22. Walsh, T. J., and A. H. Groll. 1999. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transplant. Infect. Dis. 1:247-261.
23. Yustes, C., and J. Guarro. 2005. In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp. Antimicrob. Agents Chemother. 49:3498-3500. (Pubitemid 41060604)